Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
President Donald Trump signed it on May 12, 2025. Published in the Federal Register on May 15, 2025, 90 FR 20749.
What this order does
Not checked yetPlain-language account: Not checked yet. A draft is written and a person has not finished reviewing it.
On the record
On the record: Not started.
Press releases by members of Congress
From a secondary sourceThese are press releases from members' official websites that name this order. We save a copy of each one.
4 press releases
-
“Executive Order 14297, issued on May 12, directed the U.S. Department of Commerce (Commerce) and the U.S. Trade Representative (USTR) to pursue the removal of policies and practices abroad that have “the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market”
-
Tuberville, Colleagues Call for Foreign Nations to Pay Their Share in Pharmaceutical R&D
“Executive Order 14297, issued on May 12, directed the U.S. Department of Commerce (Commerce) and the U.S. Trade Representative (USTR) to pursue the removal of policies and practices abroad that have “the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market”
-
“Executive Order 14297, issued on May 12, directed the U.S. Department of Commerce (Commerce) and the U.S. Trade Representative (USTR) to pursue the removal of policies and practices abroad that have “the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market”
-
MEDIA ADVISORY: Sanders to Call on Republicans to Support Trump, Lower Prescription Drug Prices
“On May 5, 2025, President Trump issued an executive order entitled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” In that order, he proposes a “a rulemaking plan to impose most-favored-nation pricing” but does not cite specific legislative authority.”
Read from 539 of 539 members' sites, releases since January 3, 2025, through November 22, 2026.
Press releases by organizations
No saved press release from these organizations names this order.
Read from 437 of 437 organizations' sites, releases since January 3, 2025, through November 22, 2026.
Agencies the Federal Register lists for this order
Where this comes from
We saved our own copy of the Federal Register's file for this order before writing this page. A code beside a file is its fingerprint, a short code that changes if the file's contents change.
The Federal Register's note on this order:
- See: EO 14273, April 15, 2025